Kidney Week 2019

In-Depth Focus From Kidney Week 2019: Hemodialysis-Dependent Chronic Kidney Disease

Complete Coverage

A woman scratching her skin

Novel Drug Eases Uremic Pruritus

In a phase 3 trial, difelikefalin, a kappa opioid receptor agonist, significant decreased itching and improved itching-related quality of life among dialysis patients suffering from pruritus.
Next post in Kidney Week 2019 HDD/CKD In-Depth